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Introduction
Follicular neoplasms of the thyroid gland include
benign follicular adenoma and follicular carcinoma.
Hu¨rthle cell adenoma and Hu¨rthle cell carcinoma are
considered oncocytic variants of follicular adenoma
and follicular carcinoma, respectively [1].
Currently, a follicular carcinoma cannot be
distinguished from a follicular adenoma based on
cytological, sonographic, or clinical features alone [2,
3]. The distinction between benign and malignant
follicular neoplasm can only be made by evaluating
the presence of capsular or vascular invasion on the
histological examination. Although Hu¨ rthle cell
nodules are found less frequently with respect to the
follicular pattern, histology is also needed for the final
diagnosis [1]. The estimated rate of malignancy for
follicular neoplasm is variable, ranging from 10-30%
[1, 4].
According to the Bethesda system for reporting
thyroid cytopathology, “follicular neoplasm”or
“suspicious for a follicular neoplasm”is categorized as
Bethesda IV. This result was regarded as a screening
test and a definitive diagnostic procedure such as
lobectomy is needed [5]. Patients with invasive
follicular carcinoma on final pathology are treated
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Purpose: The purpose of this study is to identify clinical and imaging parameters
that can be used in differentiation of benign versus malignancy of preoperative FNA
diagnosis of Bethesda system IV nodules. 
Materials and Methods: We analyzed clinical, ultrasonographic, and CT findings of
28 thyroid nodules with Bethesda system IV cytology on FNA, which were proven as
follicular or Hu¨rthle cell neoplasms on surgical pathology. 
Results: No statistically significant differences according to age, sex, and ultrasono-
graphic parameters, including echogenicity, margin, calcification, shape, cystic com-
ponent, and degree of vascularity and enhancement on CT were observed between
benign and malignant follicular neoplasms. Only the lesion size was significantly differ-
ent (p<0.05).
Conclusion: The size of follicular neoplasm is predictive of malignancy. If a thyroid
nodule with the Bethesda IV cytology is larger than 24.5 mm, there will be a greater
probability of malignancy. 
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with an additional total thyroidectomy with or
without remnant ablative therapy [3]. Hence,
preoperative discrimination between benign versus
malignancy is needed. However, several prior
attempts to define parameters useful for identification
of patients at higher risk of malignancy were far from
satisfactory [1].
The purpose of this study was to identify clinical
and imaging parameters that can be used in
characterization of patients with an increased risk of
having a thyroid follicular carcinoma who have
preoperative FNA diagnosis of Bethesda system IV
nodules. 
Materials and Methods
Study population
From March 2010 to August 2012, 10,252 thyroid
nodules underwent ultrasound-guided fine needle
aspiration (US-guided FNA) at our institution. Of
these, 79 (0.8%) were classified as Bethesda system IV
on cytology. Among the nodules with Bethesda system
IV, 32 were excluded for a lack of surgical treatment
and 19 lesions with other than follicular or Hu¨rthle
cell neoplasms on surgical pathology were also
excluded. A total of 28 thyroid nodules in 28 patients
were included in this study. Clinical, ultrasound (US),
computed tomography (CT), and pathologic records of
these patients were reviewed.
Thyroid Ultrasound and Image Analysis
US was performed using 7- to 15-MHz (HDI 5000;
Philips Medical Systems, Bothell, WA, USA) and 5- to
12-MHz linear array transducers (iU22; Philips
Medical Systems). Real-time US examinations were
performed by one of six radiologists with 5-15 years
of experience in thyroid imaging. US features of
thyroid nodules were analyzed prospectively by the
radiologists performing the US examination according
to echogenicity, margin, calcification, shape, cystic
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Fig. 1. Follicular adenoma in a 31-year-old woman. 
A. Longitudinal sonogram of the left lobe of the thyroid shows a circumscribed hypoechoic nodule with a hypoechoic rim. B. Color
Doppler sonogram shows central and peripheral vascularity. C, D. Axial pre-contrast and contrast enhanced CT image shows strong
enhancement of the tumor.  
component, and vascularity of the nodules [4], and the
data were entered into a database using a
computerized spreadsheet (Excel; Microsoft.
Redmond, WA, USA). 
Echogenicity was divided into hyperechoic,
isoechoic, hypoechoic, and marked hypoechoic. For
mixed solid and cystic nodules, echogenicity of the
solid components was used in the classification.
Margins were classified as circumscribed, micro-
lobulated, and irregular. Shape was designated as
either parallel or nonparallel. Calcifications were
divided into microcalcifications, macrocalcifications,
eggshell calcifications, and no calcifications.
Hypoechoic rim and cystic change were divided into
presence and absence. Vascularity was categorized as
peripheral, central, or both peripheral and central
calcifications (Figs. 1, 2). 
Thyroid CT Image Analysis
Of the 28 patients, 21 underwent neck CT. CT scans
were performed using a 64-slice multidetector CT
(MDCT) scanner (Somatom Sensation 64; Siemens
Medical Solutions, Erlangen, Germany). Scanning was
performed in a craniocaudal direction at end-
inspiratory suspension with patients in the supine
position. After acquisition of the scout image for
localization of the target lesions, we obtained pre and
post-contrast CT images. After injection of contrast
material, post-contrast images were obtained at 60
seconds. All CT data were transferred to our picture
archiving and communication system (PACS)
(Centricity 1.0; GE Medical Systems, Mt Prospect, IL,
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Fig. 2. Follicular carcinoma in a 33-year-old woman. 
A. Transverse sonogram of the left lobe of the thyroid shows a complex cystic lesion with a circumscribed margin and a hypoechoic
rim. B. Color Doppler sonogram shows internal and peripheral vascularity in the solid parts of the tumor. C, D. Axial pre-contrast and
contrast enhanced CT image shows the tumor with moderate enhancement. Cystic portion is also visible (arrow).
USA), which displayed all images on monitors (1536 ×
2048 image matrices, 60-foot-lambert luminescence).
Images were evaluated in one image interpretation
section by consensus of two radiologists (E.J.S. and
M.R.Y.) who had 20 and four years of experience in
thyroid imaging interpretation. They classified
enhancement degree of thyroid nodule on CT images
corresponding to aspirated lesion on US, as none,
moderate, or strong, blind to FNA and surgical
pathologic results (Figs. 1, 2). 
US-FNA and Cytological Analysis
US-FNA was performed by the same radiologist
performing the real-time US examinations. US-FNA
was performed using a 23-gauge needle attached to a
2-mL disposable syringe without using an aspirator.
Papanicolaou staining was performed on two alcohol-
fixed smears, while the remainder was prepared for
ThinPrep by rinsing the needle in Cyolyte (Hologic,
Marlborough, MA, USA). On-site evaluation was not
performed routinely. 
All cases were reported by one cytopathologist using
a six-tiered diagnostic system with the Bethesda
System for Reporting Thyroid Cytopathology [5].
Cytological diagnoses were made as follows: 1)
nondiagnostic or unsatisfactory (Bethesda system I), 2)
benign (Bethesda system II), 3) AUS/FLUS (Bethesda
system III), 4) follicular neoplasm or suspicious for a
follicular neoplasm (Bethesda system IV), 5)
suspicious for malignancy (Bethesda system V), and 6)
malignant (Bethesda system VI). Cellular specimens
with abundant follicular cells arranged in a
microfollicular pattern with little or no colloid or
cellular specimens with a predominant population of
Hu¨rthle cells were reported as follicular neoplasms. 
Data and Statistical Analysis
Histologic results from the surgical pathology were
used as a standard reference. A benign outcome was
defined as a benign surgical tissue diagnosis of
follicular adenoma, Hu¨rthle cell adenoma. Outcomes
were classified as malignant when a histologic
diagnosis of follicular carcinoma, Hu¨ rthle cell
carcinoma was made based on surgical resection of
the aspirated nodule. Outcome classification was
based solely on the diagnosis made on the targeted
nodule. Benign and malignant groups were compared
on the basis of the following: clinical characteristics
(age, sex); US characteristics (lesion size, composition,
echogenicity, margin, hypoechoic rim, shape,
calcification, and vascularity); CT characteristics
(degree of enhancement). Categorical variables for US
features were compared statistically for the
malignancy rate using the Student’s T-test, χ2 or
Fisher’s exact test. Receiver operating characteristic
(ROC) analysis was performed for evaluation of cutoff
values of size for prediction of the malignancy
potential. 
Statistical analyses were performed using SPSS
software (version 19.0, IBM, Somers, NY, USA).
Difference was considered statistically significant at
p<0.05.
Result
Patient Statistics 
Of the 28 patients included in our study, 20 patients
(71.4%) were female and eight patients (28.6%) were
male. The mean age of the patients was 42.3 years
(range: 21-71 years). The mean size of thyroid nodules
on US was 27.5 mm (range: 8-59 mm). Clinical
features of the patients are summarized in Table 1. No
statistically significant differences according to age,
sex were observed between the benign and malignant
groups. 
Cytopathologic Results
Of the 47 thyroid nodules classified as Bethesda
system IV on FNA that underwent thyroidectomy, six
lesions were diagnosed as follicular adenoma, and 13
lesions were diagnosed as follicular carcinoma on final
pathology. Five lesions were Hu¨rthle cell adenomas,
and four lesions were Hu¨rthle cell carcinomas. The
remainder of the lesions consisted of four adenomat-
ous hyperplasias and 15 papillary carcinomas (Table
2), which were excluded in the study population.
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Malignancy rate of Bethesda system IV nodules with
definitive surgery was 68.1%. 
US features 
Insignificant differences in echogenicity, margin,
shape, calcification, cystic component, and vascularity
were observed between follicular adenomas and
carcinomas (p>0.05). Only lesion size was significantly
different between the follicular adenoma and
carcinoma groups (p<0.05). When diagnostic criteria
for size of follicular carcinoma of more than 24.5 mm
were applied, sensitivity, specificity were 81.8%,
70.6%, respectively. 
CT features
Twenty patients underwent neck CT. Nine lesions
with adenoma on surgical pathology consisted of five
(55.6%) strongly enhanced lesions and four (44.4%)
moderately enhanced lesions; 11 lesions with
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Table 2. Surgical Histology on Thyroidectomy of Thyroid Nodules
Classified as Bethesda System IV on Fine Needle Aspiration Biopsy 
Histology Number (%)
Follicular adenoma 06 (12.8%)
Follicular carcinoma 13 (27.7%)
Hu¨rthle cell adenoma 05 (10.6%)
Hu¨rthle cell carcinoma 4 (8.5%)
Adenomatous hyperplasia 4 (8.5%)
Papillary carcinoma 15 (31.9%)
Total 47 (100%).
Table 1. Clinical Parameter, Ultrasonographic and CT Findings of Follicular and Hu¨rthle Cell Adenomas and Carcinomas 
Adenoma (n=11) Carcinoma (n=17) P-value
Age* 38.2 ± 7.4 44.9 ± 15.7 0.141
Sex Male 2 (18.2%) 6 (35.3%) 0.419
Female 9 (81.8%) 11 (64.7%)
Size (mm)* 21.2 ± 9.9 31.6 ± 14.3 0.046
Echogenicity Isoechoic 3 (27.3%) 5 (29.4%) 0.875
Hypoechoic 7 (63.6%) 9 (52.9%)
Markedly hypoechoic 1 (9.1%) 3 (17.6%)
Margin Circumscribed 11 (100%) 16 (94.1%) 1.000
Microlobulated 0 (0%) 1 (5.9%)
Irregular 0 (0%) 0 (0%)
Hypoechoic rim Presence 4 (36.4%) 10 (58.8%) 0.246
Absence 7 (63.6%) 7 (41.2%)
Shape Parallel 10 (90.9%) 14 (82.4%) 1.000
Non-parallel 1 (9.1%) 3 (17.6%)
Cystic change None 7 (63.6%) 6 (35.3%) 0.142
Presence 4 (36.4%) 11 (64.7%)
Calcification Microcalcification 0 (0%) 0 (0%) 0.361
Macrocalcification 0 (0%) 1 (5.9%)
Eggshell 0 (0%) 3 (17.6%)
None 11 (100%) 13 (76.5%)
Vascularity Peripheral 3 (27.3%) 4 (23.5%) 0.718
Central 0 (0%) 2 (11.8%)
Both 7 (63.6%) 8 (47.1%)
None 1 (9.1%) 3 (17.6%)
Enhancement on CT Strong 5 (55.6%) 6 (54.5%) 1.000
Moderate 4 (44.4%) 5 (55.6%)
Note.─ CT; computed tomography. 
*Results are given as the mean ± SD. Chi-square test, Fisher’s exact test, and unpaired Student’s t test were used for comparison of the
clinical, ultrasonographic, and CT characteristics of patients with follicular carcinoma and adenoma.
carcinoma on surgical pathology, six (54.5%) strongly
enhanced lesions, and five (45.5%) moderately
enhanced lesions. No significant difference in these
degrees of enhancement were observed between
follicular adenoma and carcinoma (p>0.05) (Table 1). 
Discussion
The cytological, clinical, and imaging distinction of
benign from malignant follicular neoplasm remains
problematic. Due to the lack of specific genetic
alterations, molecular analysis of different oncogenes
is also not helpful in the case of follicular carcinoma
[1, 6].
This study reports results obtained from 79 patients
with thyroid nodules who underwent thyroidectomy
after a cytological diagnosis of Bethesda IV.
Ultrasonographic findings, including echogenicity,
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Table 3. Clinical Parameter, Echographic Patterns, and CT Features of 41 Patients with Follicular, Hu¨rthle Cell Neoplasm and Papillary
Neoplasm on Surgical Pathology
Follicular and Hu¨rthle Papillary neoplasm
cell neoplasm (n=28) (n=15)
(n) (%) (n) (%)
Age* 42.3 ± 13.3 47.3 ± 10.8
Sex Male 08 28.6 02 13.3
Female 20 71.4 13 86.7
Size (mm)* 27.5 ± 13.6 17.3 ± 11.1
Echogenicity Hyperechoic 0 0 1 6.7
Isoechoic 8 28.6 6 40
Hypoechoic 16 57.1 7 46.7
Markedly hypoechoic 4 14.3 1 6.7
Internal echogenicity Inhomogeneous 17 60.7 6 40
homogenous 11 39.3 9 60
Margin Circumscribed 27 96.4 7 46.7
Microlobulated 1 3.6 1 6.7
Irregular 0 0 7 46.7
Hypoechoic rim Presence 14 50 4 26.7
Absence 14 50 11 73.3
Shape Parallel 24 85.7 9 60
Non-parallel 4 14.3 6 40
Cystic change None 13 46.4 13 86.7
Presence 15 53.6 2 13.3
Calcification Microcalcification 0 0 1 6.7
Macrocalcification 1 3.6 2 13.3
Eggshell calcification 3 10.7 1 6.7
None 24 85.7 11 73.3
Vascularity Peripheral 7 25 9 60
Central 2 7.1 0 0
Both 15 53.6 3 20
None 4 14.3 3 20
Underlying echotexture Homogenous 28 100 11 73.3
Heterogeneous 0 0 4 26.7
Enhancement on CT Strong 11 39.3 5 55.6
Moderate 9 32.1 4 44.4
Note.─ CT; computed tomography. 
*Results are given as the mean ± SD unless otherwise specified.
margin, calcification, shape, cystic component, and
vascularity, and clinical features, including age, sex,
did not differ significantly between follicular adenoma
and carcinoma. 
The reported ultrasonographic findings of follicular
neoplasms are a solid mass with inhomogeneous
internal echogenicity and a surrounding hypoechoic
rim. They infrequently showed an irregular margin
and intranodular calcifications [4]. In this study, 46.4%
(13 lesions) of follicular neoplasms were completely
solid, 60.7% (17 lesions) showed inhomogeneous
internal echogenicity, and 50% (14 lesions) showed a
hypoechoic rim. Calcification was found in 14.3%
(four lesions) and none of the follicular neoplasms had
an irregular margin (Table 1). 
Male gender, old age, large size, and previous history
of head and neck irradiation have been reported by
several authors as statistically significant parameters
distinguishing patients at risk [7], but not by others [1,
3, 8, 9].
Ultrasonographic features distinguishing benign and
malignancy are also controversial. Miyakawa et al.
suggested that an irregular margin without a
hypoechoic halo was more frequent in follicular
carcinomas than in follicular adenomas. They also
suggested that intranodular cystic degeneration was
rarely observed in follicular carcinomas [10]. Jeh et al
conducted a retrospective review of the ultrasono-
graphic findings of 23 patients with follicular carcino-
mas; a hypoechoic rim was observed in 86.6%, few
follicular neoplasms had calcifications (only four
among the 23 cases), however, none of the cases had
microcalcifications. A solid mass without cystic change
was observed in 82.6% of follicular carcinomas [4].
Fukunari et al. reported that no significant US patterns,
such as internal echography, calcification, or findings
of invasion are useful for a differential diagnosis that
includes follicular adenoma and carcinoma, except for
the low degree of cystic degeneration [2]. Rago et al.
claimed that, apart from the presence of spot
microcalcifications, all other previously described
ultrasound patterns suggestive of thyroid carcinoma
did not show a significant association with malignancy
[1]. 
Vascularity on color Doppler sonography was also
studied. Intranodular blood flow in a follicular
neoplasm was a characteristic finding of follicular
carcinoma in prior studies [2, 3, 11]. However, Frates
et al claimed that color Doppler imaging cannot play a
role in the differential diagnosis of thyroid cancer [12].
Doppler sonography performed in our series revealed
intranodular vascularity in seven adenomas (63.6%)
and in 10 carcinomas (58.9%). 
As a variant of follicular neoplasms, Hu¨rthle cell
neoplasms are considered to have US features similar
to those of follicular neoplasms [13]. Because of their
relative rarity, several efforts at clarification of the
differential point between the Hu¨rthle cell adenoma
and carcinoma have been made presumably but not
yet with consensus [13-15]. In our study, although not
shown here, no statistically significant difference in
the sonographic, CT parameters were observed
between follicular and Hu¨rthle cell neoplasm.
In this study, 15 papillary carcinomas were also
found on operative pathology of Bethesda IV thyroid
nodules. Eleven of them were papillary micro-
carcinomas and the remaining four of them were
papillary carcinomas. Known sonographic features of
papillary carcinoma include completely solid or
prominently solid nodule, hypoechogenicity,
compared with the strap muscles, an irregular margin,
microcalcification in the nodule, a taller than wide
orientation, and increased intranodular vascularity [4]. 
In this study, 86.7% were solid nodules, however,
hypoechogenicity accounted for only 53.4%, and
lesions with an irregular margin were 33.3%; and
26.7% presented a taller than wide shape.
Microcalcification was found in only 6.7% and
macrocalcification and eggshell calcification accounted
for 20%; and intranodular vascularity was observed in
20% of lesions (Table 3). Combination of more than
two malignant features accounted for 40.0%; and only
two lesions (13.3%) showed no malignant sonographic
features. This is in agreement with a previously
reported series of papillary carcinoma.
In conclusion, after an initial FNA result categorized
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as Bethesda system IV diagnosis, neither US nor
clinical parameter has yielded satisfactory differential
guidelines for thyroid adenoma and carcinoma, except
size of the follicular neoplasm. If a thyroid nodule is
larger than 24.5 mm, there will be a greater
probability of malignancy with sensitivity, specificity
of 81.8%, 70.6%. 
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요 약
목적: 본 연구의 목적은 수술 전 세침흡인세포검사로 베
데스다 분류 IV로 진단된 갑상선 결절 중에서 수술 병리
결과상 소포암종 또는 Hu¨rthle세포암종을 예측할 수 있는
특징적인 임상적, 영상적 소견이 있는지 알아보는데 있다. 
대상 및 방법: 본 저자는 세침흡인세포검사로 베데스다
분류IV로 진단된 갑상선 결절 중 수술 병리 검사상 소포종
양 또는 Hu¨rthle세포종양으로 진단된 28개 결절의 임상
적, 초음파, 전산화 단층촬영상 소견을 분석했다. 
결과: 양성과 악성 소포종양간에 나이, 성별, 초음파상
에코음영, 경계, 석회화, 모양, 액화 여부, 혈관분포와 CT
상 조영 증강 정도는 유의한 차이가 없었다. 단지 병변의
크기만 통계적으로 유의한 차이를 보였다. 
결론: 소포종양의 크기는 악성 여부를 예측하는 데 도움
이 된다. Bethesda IV의 갑상선 결절이 24.5 mm보다 크
면, 악성의 가능성이 높다. 
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